Russia’s recently announced cancer vaccine Enteromix is ‘ready’ for clinical use; will be made free to patients
Russia has declared its readiness to use Enteromix as a personalised cancer vaccine for clinical applications, after successful development through mRNA technology similar to COVID-19 vaccines. The vaccine has demonstrated outstanding results in initial testing, because it uses advanced mRNA technology which powers COVID-19 vaccines. The treatment provides a safer method to fight deadly cancers,…